100 related articles for article (PubMed ID: 26840964)
1. Iatrogenic Subclinical Hyperthyroidism Does Not Promote Weight Loss.
Kedia R; Lowes A; Gillis S; Markert R; Koroscil T
South Med J; 2016 Feb; 109(2):97-100. PubMed ID: 26840964
[TBL] [Abstract][Full Text] [Related]
2. Iatrogenic hyperthyroidism does not promote weight loss or prevent ageing-related increases in body mass in thyroid cancer survivors.
Polotsky HN; Brokhin M; Omry G; Polotsky AJ; Tuttle RM
Clin Endocrinol (Oxf); 2012 Apr; 76(4):582-5. PubMed ID: 22004309
[TBL] [Abstract][Full Text] [Related]
3. Weight changes in euthyroid patients undergoing thyroidectomy.
Jonklaas J; Nsouli-Maktabi H
Thyroid; 2011 Dec; 21(12):1343-51. PubMed ID: 22066482
[TBL] [Abstract][Full Text] [Related]
4. The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma.
Gülsoy Kirnap N; Turhan Iyidir Ö; Bozkuş Y; Işildak ŞM; Anil C; Firat SN; Demir C; Nar A; Başçil Tütüncü N
Turk J Med Sci; 2020 Jun; 50(4):870-876. PubMed ID: 32490648
[TBL] [Abstract][Full Text] [Related]
5. Body weight change is unpredictable after total thyroidectomy.
Glick R; Chang P; Michail P; Serpell JW; Grodski S; Lee JC
ANZ J Surg; 2018 Mar; 88(3):162-166. PubMed ID: 29444549
[TBL] [Abstract][Full Text] [Related]
6. Do patients gain weight after thyroidectomy for thyroid cancer?
Weinreb JT; Yang Y; Braunstein GD
Thyroid; 2011 Dec; 21(12):1339-42. PubMed ID: 22066475
[TBL] [Abstract][Full Text] [Related]
7. A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease.
Di Donna V; Santoro MG; de Waure C; Ricciato MP; Paragliola RM; Pontecorvi A; Corsello SM
Thyroid; 2014 Dec; 24(12):1759-64. PubMed ID: 25268754
[TBL] [Abstract][Full Text] [Related]
8. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
[TBL] [Abstract][Full Text] [Related]
9. Changes in body composition in women following treatment of overt and subclinical hyperthyroidism.
Greenlund LJ; Nair KS; Brennan MD
Endocr Pract; 2008 Nov; 14(8):973-8. PubMed ID: 19095595
[TBL] [Abstract][Full Text] [Related]
10. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy?
Tigas S; Idiculla J; Beckett G; Toft A
Thyroid; 2000 Dec; 10(12):1107-11. PubMed ID: 11201857
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Dosing Schemes for Thyroid Hormone Replacement Therapy After Thyroidectomy.
Valenzuela F; Berrios L; Robledo CA; Snyder S; Barney JM; Reinhart H; Romero Arenas MA
J Surg Res; 2021 Aug; 264():316-320. PubMed ID: 33845415
[TBL] [Abstract][Full Text] [Related]
12. Does hyperthyroidism worsen prognosis of thyroid carcinoma? A retrospective analysis on 2820 consecutive thyroidectomies.
Medas F; Erdas E; Canu GL; Longheu A; Pisano G; Tuveri M; Calò PG
J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):6. PubMed ID: 29357932
[TBL] [Abstract][Full Text] [Related]
13. Quality of life, muscle strength, and fatigue perception in patients on suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
de Oliveira Chachamovitz DS; dos Santos Vigário P; Nogueira Cordeiro MF; de Castro CL; Vaisman M; dos Santos Teixeira Pde F
Am J Clin Oncol; 2013 Aug; 36(4):354-61. PubMed ID: 22643561
[TBL] [Abstract][Full Text] [Related]
14. Levothyroxine replacement therapy after thyroid surgery.
Verhaert N; Vander Poorten V; Delaere P; Bex M; Debruyne F
B-ENT; 2006; 2(3):129-33. PubMed ID: 17067083
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial.
Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bax JJ; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Mar; 64(3):284-91. PubMed ID: 16487438
[TBL] [Abstract][Full Text] [Related]
17. Impact of thyroid dysfunction on erythropoietin dosage in hemodialysis patients.
Ng YY; Lin HD; Wu SC; Yang CY; Yang WC; Liou HH; Hu FH; Hou CC; Tseng SS; Ku NY; Hsiao NY; Wu WC; Tu HM; Lien TJ; Lee CC; Tsang KK; Cheng CS; Hu J; Lin RP
Thyroid; 2013 May; 23(5):552-61. PubMed ID: 23189968
[TBL] [Abstract][Full Text] [Related]
18. The impact of overt and subclinical hyperthyroidism on skeletal muscle.
Brennan MD; Powell C; Kaufman KR; Sun PC; Bahn RS; Nair KS
Thyroid; 2006 Apr; 16(4):375-80. PubMed ID: 16646684
[TBL] [Abstract][Full Text] [Related]
19. Levothyroxine dose following thyroidectomy is affected by more than just body weight.
Baehr KM; Lyden E; Treude K; Erickson J; Goldner W
Laryngoscope; 2012 Apr; 122(4):834-8. PubMed ID: 22374624
[TBL] [Abstract][Full Text] [Related]
20. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
